(Q43899938)

27 November 2017

Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties (English)

1 reference

27 November 2017

1

Eithan Galun

0 references

Rachel Eren

2

object named as

Rachel Eren

1 reference

27 November 2017

9

Dov Terkieltaub

1 reference

27 November 2017

14

Shlomo Dagan

1 reference

27 November 2017

12

Judith Gopher

1 reference

27 November 2017

5

Norah Terrault

1 reference

27 November 2017

Rifaat Safadi

3

1 reference

27 November 2017

Yaffa Ashour

4

1 reference

27 November 2017

Emmet B Keeffe

6

1 reference

27 November 2017

Edith Matot

7

1 reference

27 November 2017

Sara Mizrachi

8

1 reference

27 November 2017

Merav Zohar

10

1 reference

27 November 2017

Ido Lubin

11

1 reference

27 November 2017

Daniel Shouval

13

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

27 November 2017

1 reference

27 November 2017

35

1 reference

27 November 2017

3

1 reference

27 November 2017

673-679

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

27 November 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

New antiviral agents for the therapy of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Antibodies for the prevention and treatment of viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31867

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.31867

1 reference

27 November 2017

1 reference